本文選題：植物性雌激素 + 子宮肌瘤��； 參考：《中國(guó)生化藥物雜志》2014年09期

【摘要】：目的探究植物性雌激素對(duì)子宮肌瘤模型大鼠血清NOS、TNF-α、IL-2水平及子宮平滑肌厚度的影響。方法選取74只Wistar大鼠,采用腹腔注射苯甲酸雌二醇建立子宮肌瘤大鼠模型,隨機(jī)分為2組。實(shí)驗(yàn)組36例,灌胃給予植物性雌激素依普黃酮溶液,對(duì)照組38例,灌胃給予非植物性雌激素結(jié)合雌激素溶液。治療2周后,檢測(cè)并比較2組大鼠血清NOS、TNF-α及IL-2水平。結(jié)果治療后,對(duì)照組大鼠血清NOS、TNF-α水均較治療前顯著降低(P0.05),實(shí)驗(yàn)組大鼠血清NOS、TNF-α水平較治療前顯著升高(P0.05),治療后實(shí)驗(yàn)組較對(duì)照組顯著升高(P0.05)。治療后,對(duì)照組大鼠IL-2水平較治療前顯著升高(P0.05);實(shí)驗(yàn)組大鼠IL-2水平較治療前顯著下降(P0.05)。治療后,對(duì)照組大鼠子宮平滑肌厚度較治療前顯著減少(P0.05);實(shí)驗(yàn)組大鼠子宮平滑肌厚度較治療前顯著增加(P0.05);且實(shí)驗(yàn)組大鼠平滑肌厚度顯著高于對(duì)照組(P0.05)。結(jié)論植物性雌激素可升高子宮肌瘤模型大鼠血清NOS、TNF-α含量、降低血清IL-2水平,對(duì)大鼠子宮平滑肌有顯著的增厚作用,是加重子宮肌瘤模型大鼠病情的藥物,不適用于子宮肌瘤患者的治療,臨床應(yīng)對(duì)該藥物的使用進(jìn)行嚴(yán)格監(jiān)管。
[Abstract]:Objective to investigate the effects of phytoestrogen on serum NOS- TNF- 偽 and uterine smooth muscle thickness in rats with uterine leiomyoma. Methods Seventy-four Wistar rats were randomly divided into two groups by intraperitoneal injection of estradiol benzoate to establish uterine leiomyoma model. The experimental group (n = 36) received phytoestrogenin solution by gavage, and the control group (n = 38) by non-phytoestrogen binding estrogen solution. After 2 weeks of treatment, the serum levels of NOS- TNF- 偽 and IL-2 were measured and compared between the two groups. Results after treatment, the serum NOSN TNF- 偽 level in the control group was significantly lower than that in the control group (P0.05), the serum NOSN TNF- 偽 level in the experimental group was significantly higher than that in the control group (P0.05), and that in the experimental group was significantly higher than that in the control group (P0.05). After treatment, the level of IL-2 in control group was significantly higher than that before treatment (P0.05), and the level of IL-2 in experimental group was significantly lower than that before treatment (P0.05). After treatment, the thickness of uterine smooth muscle in control group was significantly lower than that before treatment (P0.05); the thickness of uterine smooth muscle in experimental group was significantly higher than that before treatment (P0.05); and the thickness of smooth muscle in experimental group was significantly higher than that in control group (P0.05). Conclusion phytoestrogen can increase the content of serum NOSN TNF- 偽 and decrease the level of serum IL-2 in rats with uterine leiomyoma, and it can significantly increase the thickness of uterine smooth muscle in rats. It is a medicine for exacerbating the condition of uterine leiomyoma model rats. Not suitable for the treatment of hysteromyoma patients, clinical use of the drug should be strictly monitored.
【作者單位】： 河北工程大學(xué)醫(yī)學(xué)院護(hù)理系;南京市鼓樓醫(yī)院婦產(chǎn)科;
【基金】：江蘇省衛(wèi)生廳項(xiàng)目(H200803)
【分類號(hào)】：R-332;R737.33

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 朱麗紅;嚴(yán)維娜;胡婷婷;;大黃釳蟲對(duì)藥對(duì)雌孕激素負(fù)荷大鼠子宮肌瘤模型雌激素及其受體的影響[J];遼寧中醫(yī)雜志;2008年11期

2 祖淑靜;項(xiàng)丹;李誼明;;仁芍消癥方對(duì)子宮肌瘤模型大鼠的影響[J];黑龍江中醫(yī)藥;2009年06期

3 朱麗紅;胡婷婷;嚴(yán)維娜;;大黃、釳蟲對(duì)藥對(duì)雌孕激素負(fù)荷大鼠子宮肌瘤模型孕激素及其受體的影響[J];時(shí)珍國(guó)醫(yī)國(guó)藥;2010年03期

4 朱麗紅;胡婷婷;嚴(yán)維娜;;大黃、釳蟲對(duì)藥對(duì)雌孕激素負(fù)荷大鼠子宮肌瘤模型血液流變學(xué)的影響[J];新中醫(yī);2009年03期

5 陸一竹;黃照環(huán);張茜薇;宋卓敏;王娜;;益氣消法對(duì)雌激素誘導(dǎo)子宮肌瘤模型豚鼠血管內(nèi)皮生長(zhǎng)因子及其受體蛋白表達(dá)的影響[J];世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化;2013年09期

6 傅萍,崔林,何嘉琳,陳少春,劉凌云,俞麗霞;血竭化瘤顆粒對(duì)子宮肌瘤模型小鼠雌孕激素及其受體的影響[J];中國(guó)中醫(yī)藥科技;2004年06期

7 李建榮;吳蘭生;張廣平;;金草片對(duì)子宮肌瘤模型大鼠免疫功能的干預(yù)作用[J];中國(guó)中藥雜志;2007年21期

8 韓立民,彭莉莉,徐彭;肌瘤消顆粒對(duì)子宮肌瘤模型大鼠干預(yù)作用的研究[J];中醫(yī)藥學(xué)刊;2004年06期

9 李建榮;吳蘭生;張廣平;仝燕;王錦玉;;金草片對(duì)子宮肌瘤模型大鼠子宮組織一氧化氮合酶表達(dá)的影響[J];中國(guó)實(shí)驗(yàn)方劑學(xué)雜志;2007年05期

10 李明真;王迪生;;桃紅消ve散對(duì)子宮肌瘤模型大鼠雌、孕激素受體表達(dá)的影響[J];中國(guó)實(shí)驗(yàn)方劑學(xué)雜志;2009年12期

相關(guān)碩士學(xué)位論文 前1條

1 韓立民;子宮肌瘤模型的復(fù)制及肌瘤消顆粒干預(yù)作用的實(shí)驗(yàn)研究[D];湖南中醫(yī)學(xué)院;2002年

，

本文編號(hào)：2058138